{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:13:07Z","timestamp":1792602787044,"version":"4.5.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To compare the safety and effectiveness of transvaginal mesh repair and native tissue repair, in response to a U.S. Food and Drug Administration (FDA) 522 study order to assess co-primary endpoints of superiority and noninferiority.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>This was a prospective, nonrandomized, parallel cohort, multi-center trial comparing transvaginal mesh with native tissue repair for the treatment of pelvic organ prolapse. The primary endpoints were composite treatment success at 36 months comprised of anatomical success (defined as pelvic organ prolapse quantification [POP-Q] point Ba\u22640 and\/or C\u22640), subjective success (vaginal bulging per the PFDI-20 [Pelvic Floor Distress Inventory]), and retreatment measures, as well as rates of serious device-related or serious procedure-related adverse events. Secondary endpoints included a composite outcome similar to the primary composite outcome but with anatomical success defined as POP-Q point Ba&lt;0 and\/or C&lt;0, quality-of-life measures, mesh exposure and mesh- and procedure-related complications. Propensity score stratification was applied.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Primary endpoint composite success at 36 months was 89.3% (201\/225) for transvaginal mesh and 80.2% (389\/485) for native tissue repair, demonstrating noninferiority at the preset margin of 12% (propensity score\u2013adjusted treatment difference 6.5%, 90% CI \u22120.2% to 13.2%). Using the primary composite endpoint, transvaginal mesh was not superior to native tissue repair (<jats:italic toggle=\"yes\">P<\/jats:italic>=.056). Using the secondary composite endpoint, superiority of transvaginal mesh over native tissue repair was noted (<jats:italic toggle=\"yes\">P<\/jats:italic>=.009), with a propensity score\u2013adjusted difference of 10.6% (90% CI 3.3\u201317.9%) in favor of transvaginal mesh. Subjective success for both the primary and secondary endpoint was 92.4% for transvaginal mesh, 92.8% for native tissue repair, a propensity score\u2013adjusted difference of \u22124.3% (CI \u221212.3% to 3.8%). For the primary safety endpoint, 3.1% (7\/225) of patients in the transvaginal mesh (TVM) group and 2.7% (13\/485) of patients in the native tissue repair (NTR) group developed serious adverse events, demonstrating that transvaginal mesh was noninferior to native tissue repair (\u22120.4%, 90% CI \u22122.7% to 1.9%). Overall device-related and\/or procedure-related adverse event rates were 35.1% (79\/225) in the TVM group and 46.4% (225\/485) in the NTR group (\u221215.7%, 95% CI \u221224.0% to \u22127.5%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Transvaginal mesh repair for the treatment of anterior and\/or apical vaginal prolapse was not superior to native tissue repair at 36 months. Subjective success, an important consideration from the patient-experience perspective, was high and not statistically different between groups. Transvaginal mesh repair was as safe as native tissue repair with respect to serious device-related and\/or serious procedure-related adverse events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>FUNDING SOURCE:<\/jats:title>\n            <jats:p>This study was sponsored by Boston Scientific and developed in collaboration with FDA personnel from the Office of Surveillance and Biometrics, Division of Epidemiology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n            <jats:p>ClinicalTrials.gov, NCT01917968.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000004794","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T11:00:24Z","timestamp":1654167624000},"page":"975-985","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":28,"title":["Transvaginal Mesh Compared With Native Tissue Repair for Pelvic Organ Prolapse"],"prefix":"10.1097","volume":"139","author":[{"given":"Bruce","family":"Kahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Edward","family":"Varner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lioudmila","family":"Lipetskaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen E.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Mahdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Noblett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"R1-20250423","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s00192-013-2169-9","article-title":"Epidemiology and outcome assessment of pelvic organ prolapse","volume":"24","author":"Barber","year":"2013","journal-title":"Int Urogynecol J"},{"key":"R2-20250423","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00192-010-1106-4","article-title":"Depressive symptoms in women seeking surgery for pelvic organ prolapse","volume":"21","author":"Ghetti","year":"2010","journal-title":"Int Urogynecol J"},{"key":"R3-20250423","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/jama.2014.1719","article-title":"Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial","volume":"311","author":"Barber","year":"2014","journal-title":"JAMA"},{"key":"R4-20250423","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s00192-020-04271-y","article-title":"Outcomes of native tissue transvaginal apical approaches in women with advanced pelvic organ prolapse and stress urinary incontinence","volume":"31","author":"Meyer","year":"2020","journal-title":"Int Urogynecol J"},{"key":"R5-20250423","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1056\/NEJMoa1009521","article-title":"Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse","volume":"364","author":"Altman","year":"2011","journal-title":"N Engl J Med"},{"key":"R6-20250423","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1471-0528.2007.01606.x","article-title":"Vaginal surgery for pelvic organ prolapse using mesh and a vaginal support device","volume":"115","author":"Carey","year":"2008","journal-title":"BJOG"},{"key":"R7-20250423","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/AOG.0b013e31816a2489","article-title":"Outcome after anterior vaginal prolapse repair: a randomized controlled trial","volume":"111","author":"Nguyen","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R8-20250423","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/AOG.0000000000001451","article-title":"Graft and mesh use in transvaginal prolapse repair: a systematic review","volume":"128","author":"Schimpf","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R10-20250423","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/j.1471-0528.2011.03082.x","article-title":"Primary surgical repair of anterior vaginal prolapse: a randomised trial comparing anatomical and functional outcome between anterior colporrhaphy and trocar-guided transobturator anterior mesh","volume":"118","author":"Vollebregt","year":"2011","journal-title":"BJOG"},{"key":"R12-20250423","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0002-9378(96)70243-0","article-title":"The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction","volume":"175","author":"Bump","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20250423","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajog.2004.12.025","article-title":"Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7)","volume":"193","author":"Barber","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R14-20250423","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00192-003-1063-2","article-title":"A short form of the Pelvic Organ Prolapse\/Urinary Incontinence Sexual Questionnaire (PISQ-12)","volume":"14","author":"Rogers","year":"2003","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"R15-20250423","first-page":"AlboVol8No1","article-title":"The Trial of Mid-Urethral Slings (TOMUS): design and methodology","volume":"8","year":"2008","journal-title":"J Appl Res"},{"key":"R16-20250423","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00192-009-1069-5","article-title":"Validation of the patient global impression of improvement (PGI-I) for urogenital prolapse","volume":"21","author":"Srikrishna","year":"2010","journal-title":"Int Urogynecol J"},{"key":"R17-20250423","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/AOG.0b013e318203e6a5","article-title":"Trocar-guided mesh compared with conventional vaginal repair in recurrent prolapse: a randomized controlled trial","volume":"117","author":"Withagen","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R18-20250423","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9378(98)70245-5","article-title":"Sacrospinous ligament fixation and modified McCall culdoplasty during vaginal hysterectomy for advanced uterovaginal prolapse","volume":"179","author":"Colombo","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"R19-20250423","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ajog.2003.08.031","article-title":"Abdominal sacral colpopexy or vaginal sacrospinous colpopexy for vaginal vault prolapse: a prospective randomized study","volume":"190","author":"Maher","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R20-20250423","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/0002-9378(92)91567-T","article-title":"Preoperative and postoperative analysis of site-specific pelvic support defects in 81 women treated with sacrospinous ligament suspension and pelvic reconstruction","volume":"166","author":"Shull","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"R21-20250423","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0002-9378(96)70084-4","article-title":"Vaginal versus abdominal reconstructive surgery for the treatment of pelvic support defects: a prospective randomized study with long-term outcome evaluation","volume":"175","author":"Benson","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"R22-20250423","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/AOG.0b013e318195888d","article-title":"Complication and reoperation rates after apical vaginal prolapse surgical repair: a systematic review","volume":"113","author":"Diwadkar","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R23-20250423","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10543400601044691","article-title":"Statistical and regulatory issues with the application of propensity score analysis to nonrandomized medical device clinical studies","volume":"17","author":"Yue","year":"2007","journal-title":"J Biopharm Stat"},{"key":"R24-20250423","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D'Agostino","year":"1998","journal-title":"Stat Med"},{"key":"R25-20250423","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"R26-20250423","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/jama.2019.12812","article-title":"Effect of vaginal mesh hysteropexy vs vaginal hysterectomy with uterosacral ligament suspension on treatment failure in women with uterovaginal prolapse: a randomized clinical trial","volume":"322","author":"Nager","year":"2019","journal-title":"JAMA"},{"key":"R27-20250423","doi-asserted-by":"crossref","first-page":"153.e1","DOI":"10.1016\/j.ajog.2021.03.012","article-title":"Effect of sacrospinous hysteropexy with graft vs vaginal hysterectomy with uterosacral ligament suspension on treatment failure in women with uterovaginal prolapse: 5-year results of a randomized clinical trial","volume":"225","author":"Nager","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"R28-20250423","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/SPV.0000000000000853","article-title":"Joint position statement on the management of mesh-related complications for the FPMRS specialist","volume":"26","year":"2020","journal-title":"Female Pelvic Med Reconstr Surg"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004794","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T19:02:33Z","timestamp":1745434953000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004794","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"assertion":[{"value":"2021-11-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}